Implantable cardioverter defibrillators: update

L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)
Record ID 32003000002
Authors' objectives:

This review consists of a clinical and economic evaluation of implantable cardiac defibrillators (ICDs), comparing them with drug therapies in the treatment of malignant ventricular arrhythmias. This report updates a 1997 ANAES report.

Authors' recommendations: From this literature review it can be concluded that ICDs are usually superior and never inferior to drug therapies with regard to global survival in the indications that have been evaluated in primary and secondary prevention. In primary prevention, relevant clinical risk markers (such as ventricular dysfunction) and electrical risk markers have yet to be defined. The indications and procedures for ICD insertion have now been validated both internationally and in France (Guidelines published by the French Cardiology Society). However, while insertion procedures are well-defined, ICD tariffs and reimbursement procedures are not. This paradoxical situation may partly explain the low number of insertions carried out to date in France.
Authors' methods: Review
Project Status: Completed
URL for project:
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: France
MeSH Terms
  • Costs and Cost Analysis
  • Defibrillators, Implantable
Organisation Name: L'Agence Nationale d'Accreditation d'Evaluation en Santé
Contact Address: 2 avenue du Stade de France, 93218 Saint-Denis La Plaine Cedex, France. Tel: +33 01 55 93 71 88; Fax: +33 01 55 93 74 35;
Contact Name:
Contact Email:
Copyright: L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.